QCM
GMAB icon

Quantinno Capital Management’s Genmab GMAB Stock Holding History

Quantinno Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.16M Buy
333,388
+50,890
+18% +$1.35M 0.01% 1015
2026
Q1 		$7.58M Buy
282,498
+35,588
+14% +$1.07M 0.01% 976
2025
Q4 		$7.6M Buy
246,910
+37,075
+18% +$1.16M 0.02% 887
2025
Q3 		$6.44M Buy
209,835
+51,703
+33% +$1.26M 0.02% 831
2025
Q2 		$3.27M Buy
158,132
+62,226
+65% +$1.28M 0.01% 960
2025
Q1 		$1.88M Buy
95,906
+5,571
+6% +$117K 0.01% 998
2024
Q4 		$1.89M Buy
90,335
+66,128
+273% +$1.45M 0.02% 870
2024
Q3 		$590K Buy
24,207
+8,766
+57% +$234K 0.01% 1079
2024
Q2 		$388K Sell
15,441
-8,261
-35% -$234K 0.01% 1093
2024
Q1 		$709K Sell
23,702
-20,888
-47% -$614K 0.02% 850
2023
Q4 		$1.42M Buy
44,590
+28,038
+169% +$880K 0.05% 506
2023
Q3 		$584K Buy
16,552
+2,928
+21% +$112K 0.03% 686
2023
Q2 		$518K Buy
13,624
+1,766
+15% +$70.4K 0.03% 622
2023
Q1 		$448K Buy
11,858
+2,416
+26% +$92.9K 0.03% 616
2022
Q4 		$400K Buy
+9,442
New +$389K 0.03% 597

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quantinno Capital Management's GMAB Position: Q2 2026 in Review

Quantinno Capital Management increased its Genmab (GMAB) stake by 18% in Q2 2026, buying an estimated $1.35M and bringing the position to 333,388 shares worth $9.16M. The position accounts for 0.01% of the portfolio, ranked #1015.

Quantinno Capital Management first reported a position in GMAB in Q4 2022 and has held it in 15 quarters since. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Quantinno Capital Management held 333,388 shares of Genmab worth $9.16M as of Q2 2026.
  • Quantinno Capital Management bought 50,890 Genmab shares in Q2 2026, an estimated $1.35M.
  • Genmab made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1015 holding.
  • Quantinno Capital Management first reported a position in Genmab in Q4 2022 and has held it in 15 quarters since.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.